NCT02105350 2018-02-19A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary CancerUniversity Health Network, TorontoPhase 1 Withdrawn
NCT01830322 2013-08-14Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic CancerCornerstone PharmaceuticalsPhase 2 Withdrawn
NCT01834183 2013-06-19Tivozanib + Gemcitabine in Metastatic RCCDana-Farber Cancer InstitutePhase 2 Withdrawn